HLB Pharmaceutical (Korea) Price History

047920 Stock  KRW 22,500  400.00  1.75%   
If you're considering investing in HLB Stock, it is important to understand the factors that can impact its price. As of today, the current price of HLB Pharmaceutical stands at 22,500, as last reported on the 29th of November, with the highest price reaching 23,000 and the lowest price hitting 22,200 during the day. HLB Pharmaceutical retains Efficiency (Sharpe Ratio) of -0.0477, which attests that the entity had a -0.0477% return per unit of return volatility over the last 3 months. HLB Pharmaceutical exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out HLB Pharmaceutical's Coefficient Of Variation of (3,775), market risk adjusted performance of 0.8149, and Standard Deviation of 4.77 to validate the risk estimate we provide.
  
HLB Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.0477

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns047920

Estimated Market Risk

 5.0
  actual daily
44
56% of assets are more volatile

Expected Return

 -0.24
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.05
  actual daily
0
Most of other assets perform better
Based on monthly moving average HLB Pharmaceutical is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of HLB Pharmaceutical by adding HLB Pharmaceutical to a well-diversified portfolio.

HLB Pharmaceutical Stock Price History Chart

There are several ways to analyze HLB Stock price data. The simplest method is using a basic HLB candlestick price chart, which shows HLB Pharmaceutical price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceSeptember 13, 202428000.0
Lowest PriceNovember 14, 202417150.0

HLB Pharmaceutical November 29, 2024 Stock Price Synopsis

Various analyses of HLB Pharmaceutical's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell HLB Stock. It can be used to describe the percentage change in the price of HLB Pharmaceutical from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of HLB Stock.
HLB Pharmaceutical Price Daily Balance Of Power(0.50)
HLB Pharmaceutical Price Action Indicator(300.00)
HLB Pharmaceutical Price Rate Of Daily Change 0.98 
HLB Pharmaceutical Accumulation Distribution 7,099 
HLB Pharmaceutical Market Facilitation Index 0 

HLB Pharmaceutical November 29, 2024 Stock Price Analysis

When benchmark price declines in a down market, there may be an uptick in HLB Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use HLB Pharmaceutical intraday prices and daily technical indicators to check the level of noise trading in HLB Stock and then apply it to test your longer-term investment strategies against HLB.

HLB Stock Price History Data

The price series of HLB Pharmaceutical for the period between Sat, Aug 31, 2024 and Fri, Nov 29, 2024 has a statistical range of 10850.0 with a coefficient of variation of 15.0. The prices are distributed with arithmetic mean of 23192.88. The median price for the last 90 days is 23700.0. The company had 3:2 stock split on 12th of April 2016.
OpenHighLowCloseVolume
11/28/2024 22,700  23,000  22,200  22,500  204,099 
11/27/2024 23,400  23,600  22,700  22,900  265,497 
11/26/2024 24,150  24,200  23,100  23,400  309,489 
11/25/2024 23,850  24,350  23,100  24,100  708,109 
11/22/2024 22,400  26,050  21,800  23,700  2,560,764 
11/21/2024 21,500  22,000  21,050  21,800  516,555 
11/20/2024 21,200  22,400  20,950  21,500  729,691 
11/19/2024 23,300  23,350  21,250  21,950  2,510,933 
11/18/2024 17,500  22,750  17,330  22,750  1,716,916 
11/15/2024 17,150  17,580  16,920  17,500  140,435 
11/14/2024 17,190  17,620  17,050  17,150  141,370 
11/13/2024 17,460  17,510  17,070  17,190  134,088 
11/12/2024 17,550  17,800  17,110  17,490  227,744 
11/11/2024 17,870  17,900  17,300  17,650  229,685 
11/08/2024 18,170  18,440  17,950  18,050  123,690 
11/07/2024 18,220  18,310  17,670  18,020  183,163 
11/06/2024 18,860  19,050  18,190  18,220  184,613 
11/05/2024 19,350  19,530  18,760  18,850  118,084 
11/04/2024 18,910  19,670  18,650  19,480  126,124 
11/01/2024 19,530  19,530  18,900  18,910  120,945 
10/31/2024 19,290  19,590  19,020  19,540  101,179 
10/30/2024 19,530  20,000  19,290  19,290  90,194 
10/29/2024 20,250  20,350  19,380  19,610  144,282 
10/28/2024 19,700  20,600  19,600  20,150  199,673 
10/25/2024 19,300  19,550  18,650  19,490  256,552 
10/24/2024 20,000  20,200  19,430  19,440  253,216 
10/23/2024 20,700  21,000  20,000  20,300  174,240 
10/22/2024 21,350  21,500  20,750  20,800  135,899 
10/21/2024 20,900  21,550  20,300  21,550  202,355 
10/18/2024 20,700  21,050  20,350  20,950  172,726 
10/17/2024 21,300  21,450  20,850  20,850  123,671 
10/16/2024 21,500  21,550  20,900  21,300  164,106 
10/15/2024 20,550  21,550  20,500  21,550  262,200 
10/14/2024 21,300  21,450  19,980  20,550  512,203 
10/11/2024 21,000  22,500  20,950  21,700  821,933 
10/10/2024 24,250  24,550  23,150  24,050  334,097 
10/08/2024 25,000  25,100  24,150  24,250  269,137 
10/07/2024 26,550  26,800  25,300  25,350  232,119 
10/04/2024 25,600  25,950  25,200  25,600  129,594 
10/02/2024 25,800  26,000  25,550  25,600  117,206 
09/30/2024 26,050  26,350  25,550  26,100  135,446 
09/27/2024 26,600  26,600  26,100  26,100  154,509 
09/26/2024 26,300  27,000  26,150  26,600  220,103 
09/25/2024 27,750  27,850  26,700  26,800  270,723 
09/24/2024 27,450  27,850  27,050  27,600  222,382 
09/23/2024 28,400  29,650  27,550  27,550  812,656 
09/20/2024 27,650  28,450  26,900  27,650  520,009 
09/19/2024 28,600  28,750  25,750  27,050  671,516 
09/13/2024 27,400  28,300  27,000  28,000  296,173 
09/12/2024 26,700  27,750  26,700  27,300  200,613 
09/11/2024 26,850  27,250  26,350  26,900  180,157 
09/10/2024 27,900  27,950  26,550  26,650  342,146 
09/09/2024 26,000  28,350  26,000  27,900  687,349 
09/06/2024 26,950  26,950  25,700  26,250  199,192 
09/05/2024 26,700  27,350  26,350  26,850  238,479 
09/04/2024 26,000  27,150  25,750  26,550  199,169 
09/03/2024 27,600  27,800  26,650  26,800  244,238 
09/02/2024 27,400  27,800  26,900  27,550  338,884 
08/30/2024 25,700  27,700  25,450  27,250  686,970 
08/29/2024 25,500  26,200  25,350  25,700  209,168 
08/28/2024 25,900  26,500  25,600  25,650  196,150 

About HLB Pharmaceutical Stock history

HLB Pharmaceutical investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for HLB is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in HLB Pharmaceutical will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing HLB Pharmaceutical stock prices may prove useful in developing a viable investing in HLB Pharmaceutical
HLB Pharmaceutical Co., Ltd, a pharmaceutical company, develops peptide drugs in South Korea. HLB Pharmaceutical Co., Ltd was founded in 1998 and is headquartered in Namyangju, South Korea. HLBPHARMA is traded on Korean Securities Dealers Automated Quotations in South Korea.

HLB Pharmaceutical Stock Technical Analysis

HLB Pharmaceutical technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of HLB Pharmaceutical technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of HLB Pharmaceutical trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Equity Forecasting Now

   

Equity Forecasting

Use basic forecasting models to generate price predictions and determine price momentum
All  Next Launch Module

HLB Pharmaceutical Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for HLB Pharmaceutical's price direction in advance. Along with the technical and fundamental analysis of HLB Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of HLB to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Complementary Tools for HLB Stock analysis

When running HLB Pharmaceutical's price analysis, check to measure HLB Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy HLB Pharmaceutical is operating at the current time. Most of HLB Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of HLB Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move HLB Pharmaceutical's price. Additionally, you may evaluate how the addition of HLB Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing